The Scientist - Home

The key to averting cataclysmic events, such as pandemics, climate change, and mass extinction of species, lies partly in what’s on our plates.

Researchers overseeing the clinical trial for the first FDA-approved oral contraceptive claimed the drug gave the Puerto Rican participants power over their family planning. Critics claimed the women were exploited.

The MIT biologist studies how RNA molecules self-assemble and the role these accumulations may play in diseases such as ALS and Huntington’s.

A survey of more than 200 whale skulls has unveiled bursts of evolution over the past 50 million years.

It’s not clear whether, or how, the organisms might play a role in disease pathology.

Polluted air impedes the trees’ ability to read one another’s signals, a study finds.

Researchers say there may be similar, human genes whose effects on lifespan vary by sex.

King Charles III has a long history of promoting homeopathic or alternative medical treatments not supported by scientific evidence.

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

The Biogen-developed treatment, called lecanemab, appears to have a more clear-cut effect on slowing the disease than the company’s previous Alzheimer’s drug, Aduhelm.

Mahi-mahi were more likely to be eaten and less likely to spawn after being exposed to sublethal concentrations of oil, raising concerns about the risks oceanic drilling pose to life in the ocean.

This year’s awards recognize work on integrins, noninvasive prenatal screening, and COVID-19 data tracking.